Stocks to sell

A few months ago, the Federal Reserve was talking about “transitory” inflation. The governors at the Fed meant that while inflation was rising swiftly, it wasn’t going to last. But inflation kept rising at a brisk clip and the Fed started to be less sanguine about the transitory nature of inflation. It hedged by telling

Ocugen (NASDAQ:OCGN) is a small biotech firm. For years, it tried unsuccessfully to commercialize therapies for eye diseases. However, in 2020, it ended a Phase 3 trial on that front and pivoted to Covid-19. Its first effort in that regard, Covid-19 testing, totally failed to take off. The company is nothing if not persistent, however,

I fully understand why it’s very tempting to buy Alibaba (NASDAQ:BABA) stock at this point. The company’s shares have tumbled a great deal in the last six months, yet the company remains one of the biggest and most successful e-commerce players on the planet, and its cloud business is still growing rapidly. Source: BigTunaOnline /

With shares moving up following the acquisition of Nanotech, is it time to buy Meta Materials (NASDAQ:MMAT) stock, ahead of its revenues taking off? Not so fast. It’s still down big from the high prices it hit when it first appeared on the radar of meme stock investors. But at $5.31 per share, this smart

Israeli online freelancer platform Fiverr (NYSE:FVRR) is the definition of a mixed bag. The company has some key strengths that are balanced out by some equally important weaknesses. I typically find it’s best to avoid companies like this unless their shares are trading at a very attractive valuation. In the case of FVRR stock, that

There are a few reasons why investors piled into Clover Health (NASDAQ:CLOV) stock this year. It was a popular SPAC stock headed by the charismatic Chamath Palihapitaya. And its Jan. 8 merger with Social Capital Hedosophia, a SPAC, made many investors aware of the company. Clover is a Medicare insurance services provider.  Source: Shutterstock But

Zoom Video Communications (NASDAQ:ZM) was one of the prime beneficiaries of the coronavirus pandemic. It closed out 2020 with a colossal run rate of $3.5 million in revenues. However, judging from recent results, its top- and bottom-line growth are slowing as we inch closer to a post-pandemic reality. Moreover, ZM stock is incredibly overvalued based

When you have nearly 3 billion monthly active users, some things are bound to go wrong. As the adage goes, you can please some of the people all of the time, you can please all of the people some of the time, but you can’t please all of the people all of the time. That

To put it succinctly, there isn’t very much making Lemonade (NYSE:LMND) stock attractive at present. Source: Stephanie L Sanchez / Shutterstock.com Yes, there’s news that the insurance company is launching a new service for pets. That will expand the company’s product mix beyond life, homeowners, and renters insurance. And Lemonade already announced a car insurance

Meta Materials (NASDAQ:MMAT), a Canadian company that develops nanocomposite materials and products, just closed on its first major acquisition in the nanotech field. The good news is that this acquisition will bring in much more revenue than the measly $624,000 Meta Materials made in its second quarter. The bad news is that the highly inflated

A few months back, ChargePoint (NYSE:CHPT) stock had plenty of positive catalysts that were helping it move higher or, at the very least, hold steady. Not only  was the U.S. bipartisan Infrastructure bill helping to sustain buzz about the shares, but the market was highly favorable to speculative growth stocks. Source: YuniqueB / Shutterstock.com But

Alibaba (NYSE:BABA) seemed like a solid investment for much of 2020. BABA stock bounced back quickly after the March 2020 stock market crash. Powered by China’s early recovery from the pandemic, by the end of last October, BABA closed at an all-time high. Source: Kevin Chen Photography / Shutterstock.com When it closed at $317.14 October

Investors who are still holding onto shares of ContextLogic (NASDAQ:WISH) stock should dump the stock now before there’s nothing left. Source: sdx15 / Shutterstock.com WISH stock plummeted 28% in the last month, bringing its total decline for the year to 71%. It’s flirting with the $5 mark, which would make it a penny stock. Shareholders

While I could get into a complicated argument about Greenidge Generation (NASDAQ:GREE), I think my colleague Alex Sirois said it best and said it succinctly: “There is now no reason to be invested” in GREE stock following the underlying company’s merger with Support.com in mid-September. Source: Shutterstock Since the mid-September merger, Greenidge shares have done

My editors asked me to give my 2 cents about SmileDirectClub (NASDAQ:SDC), the direct-to-consumer medtech platform that’s supposed to make your smile look like a million bucks. Unfortunately, for IPO investors, SDC stock has been anything but a millionaire-maker since going public in September 2019 at $23 a share.  Source: Thamyris Salgueiro / Shutterstock.com SDC

After Palantir (NYSE:PLTR) lost a major  government contract this year and is reportedly on the verge of losing another one, the longer-term outlook of PLTR stock remains negative. Source: Ascannio / Shutterstock.com The news indicates that Palantir could be at risk of losing additional, meaningful deals in the public sector. What’s more, the reports undermine

Cowen (NYSE:COWN) is a U.S.-based financial services firm. COWN stock had a tremendous run throughout late 2020 and into 2021 after the pandemic’s stock market craze. Source: shutterstock.com/CC7 Cowen stock has grown by more than 260% since March 2020, but it’s time for a reversal as markets seek stability. The notion is that financials will

Hyliion Holdings Corp (NYSE:HYLN) is an electric vehicle (EV) stock that’s different. Instead of cars, Hyliion is developing technology to electrify Class 8 trucks. This is a huge potential market. As a result, HYLN stock surged last fall, with the prospect of a government push to electrify commercial transportation fleets. Source: Scharfsinn / Shutterstock.com However,

Shares of veterinary health company Zomedica (NYSE:ZOM) skyrocketed earlier this year, but have since plunged more than 80% from their peak. Investors had high hopes that its point-of-care diagnostics system, Truforma, would gain a lot of traction fast. However, that hasn’t been the case, with the company managing a measly $29,817 in sales in the

SmileDirectClub (NASDAQ:SDC) is all about straightening teeth using a telehealth approach by selling its teeth aligners directly online. But after looking at the company’s lousy Q2 earnings release, there wasn’t much to smile about. In effect, SDC stock will likely tread water until SmileDirectClub becomes profitable. Source: Thamyris Salgueiro / Shutterstock.com This is nothing new